Zacks

In a report published Wednesday, Zacks reiterated its Outperform rating and $9.50 price target on POZEN (NASDAQ: POZN). Zacks noted, “The phase 3 clinical data on Pozen s PA-325/40 product has been presented now at three high-profile medical meetings, ACG in October 2012, AHA in November 2012, and...

Zacks downgraded Pure Bioscience (NASDAQ: PURE) from Outperform to Neutral with a $1.75 price target. Zacks said, "[W]e are concerned about the slow sales ramp for the Company s SDC products. Although its lead product PURE Hard Surface is increasingly gaining recognition, sales may take longer...

Coffee distributors far and wide are praying for Starbucks (NASDAQ: SBUX) to hit some type of snafu, as the coffee giant has noticeably dominated the market in recent weeks, forcing analysts to raise its rating/estimates and lower those of the competition. Within the last month, Starbucks stock...

Zacks reiterates its Outperform rating and $8.50 price target on Clean Diesel Tech (NASDAQ: CDTI) as the company expects a big fourth quarter. Zacks says, "Clean Diesel Technologies announced that the fourth quarter is expected to be largest revenue quarter in 2011. In the third quarter it...

Power-One (NASDAQ: PWER) shares are down ~4% since market open and has been called one of today's worst performing stocks by Financial News Network Online, which also points out that Power-One has traded 1 million shares today vs. its average volume of 3.4 million. So what gives? On October 28...

Zacks is out with its report today on FutureFuel (NYSE: FF), initiating FF at Outperform. In its report, Zacks writes, "FutureFuel is a profitable manufacturer and seller of specialty chemicals. We are initiating coverage with an Outperform rating and a price target of $16.00." Shares of FF...

Zacks is out with its report today on EpiCept (NASDAQ: EPCT), maintaining Outperform. In its report, Zacks writes, "The Company s lead cancer candidate Ceplene has been already approved in EU and Israel for the remission maintenance of AML and a pivotal trial is planned in the US. The Company s...

Zacks is out with its report today on S&W Seed (NASDAQ: SANW), maintaining Outperform. In its report, Zacks writes, "S&W Seed is a profitable developer of drought and salt resistant alfalfa seed varieties. The company has unused processing capacity that, when utilized, provides significant...

Zacks initiated its coverage of iCAD (NASDAQ: ICAD) with Neutral. On Tuesday, ICAD closed the day at $1.

Zacks has downgraded First Business Financial Services (NASDAQ: FBIZ) from Outperform to Neutral and maintains its $14.25 price target.

CIGNA (NYSE: CI) and Forest Laboratories (NYSE: FRX) reached new 52-week highs of $50.70 and $37.87 per share, respectively, on Thursday but were lower in premarket trading Friday. CIGNA was raised to Outperform as yesterday's Bull of the Day at Zacks. The company has a market cap of $13.6...

According to Zacks, S&W Seed (NASDAQ: SANW) third quarter results show improving gross margins. Zacks said that the company has signed a five year sales contract with PureCircle, the world's largest producer of Stevia sweeteners, for production quantities of dried Stevia leaf. “We have held...

Zacks maintains its Outperform rating and a PT of $110 on AMERCO Inc. (NASDAQ: UHAL). In the report, Zacks writes, “The impact of the decline in housing and a decrease in apartment occupancy rates appears to have ended. We expect continued improvements in operating parameters. Our recommendation...

Apartment real estate investment trusts are getting a boost from analysts at several firms this week. A measure of apartment vacancy rates fell for the first time in three years, during the second quarter. Research firm, Reis concluded that vacancy rates fell 0.2 percent to 7.8, over the second...